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The recently developed MALDI TOF-TOF instrument yields relatively complex but interpret-
able fragmentation spectra. When coupled with a straightforward sequence extension algo-
rithm, it is possible to develop complete peptide sequences de novo from the spectra. This
approach has been applied to a set of peptides derived from typtic digestion of electrophoreti-
cally separated sea urchin egg membrane proteins. When directed to proteins that have been
described previously, the results were in essential agreement with those obtained by
conventional data base searching approaches, with certain important exceptions. The present
method detected errors in published sequences and was able to develop sequences from
peptides differing in mass by one dalton (Da). These results show both the power of the
present approach and the need for using de novo methods more frequently than may be
otherwise appreciated. (J Am Soc Mass Spectrom 2002, 13, 784–791) © 2002 American Society
for Mass Spectrometry
Mass spectrometry has become an invaluabletool for the characterization of proteins, andcan be used to measure the molecular weights
of intact polypeptides determining peptide identity and
delineate peptide structure. Identification of biochemi-
cally isolated proteins that are represented in data
bases, either as translations of polynucleotide sequences
or as independently determined amino acid sequences,
may be the largest current application of mass spectro-
metry in the emerging field of proteomics. Protein
identifications are accomplished using several ap-
proaches, often in combination. MALDI-TOF is the first
method employed; exact masses of peptides resulting
from endoprotease digestions are used in conjunction
with a number of data base searching routines [1–7]. An
alternative strategy is the use of MS/MS to obtain mass
spectra of peptide fragment ions from a particular
peptide precursor ion. These MS/MS approaches tend
to be dominated by fragment spectra produced in
multiple low energy collision reactions either in triple
quadrupole or ion trap instruments. To identify the
proteins, the observed low energy fragment ion spec-
trum is matched with one that is predicted for a peptide
of the same precursor mass found in a data base [8]. An
alternative to spectra matching is the use of the se-
quence tag, a short string of sequence surrounded by
two regions of known mass, developed by Mann and
colleagues [9].
A fundamental assumption made by any of the
various data base searching routines is that the proteins
that were originally isolated for mass spectrometric
study are described in a data base either specifically or
in a closely homologous form. As various genome
projects continue to produce results, this assumption
becomes increasingly true, but is likely to remain some-
what problematic for the foreseeable future. This prob-
lem is due to a combination of the wide range of
potential organisms used as model systems coupled
with both an inability to accurately predict the proteins
produced by a genome and a small but real error rate in
the experimentally determined genomic sequences. An
additional possible weakness of protein identification
schemes involving data base searching lies in the realm
of unanticipated or unknown post-translational modi-
fications. Characterizing proteins that fall into such
gaps of the data base searching routines is the subject of
the present work.
Sequences of unknown peptides may be determined
by chemical and enzymatic means [10] without resort-
ing to mass spectrometry. In general however, these
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approaches are hampered both by post-translational
modifications of amino acids, particularly at the termi-
nal residues, and by the need for relatively large
amounts of material. On the other hand, de novo
sequencing by mass spectrometry is not yet widely
used, most likely because of the difficulties associated
with interpretation of high and low energy CID spectra.
Additionally, successful de novo sequencing requires
full sequence coverage, thus demanding better quality
spectra than those typically used for data base search-
ing. Beginning with electron ionization spectra of pep-
tides [11], and applied to FAB spectra [12], a method of
developing small peptide sub-sequences that could be
extended to progressively larger fragments was devel-
oped and later applied to both high and low energy CID
spectra [13, 14].
A very different alternative approach is presented in
a recent paper [15]. The authors employ a novel exten-
sion of tandem mass spectrometry, available only for
tandem-in-time trapping instruments, in which correla-
tions between first and second order fragmentation
spectra (MS3/MS2) are used to determine sequences de
novo.
To date, however, the most fruitful approaches to de
novo sequencing have employed the principles of
graph theory to both low [16–19] and high energy CID
spectra [20]. The advantage to these methods is that
sequences are built from the data directly, and rely on
the spectra themselves rather than on predictions of
sequence. With these theoretical schemes, it is possible
to develop results directly from the observed data. We
find that the MS/MS spectra produced by the TOF-TOF
are of such a quality that sequence determinations
based strictly on these spectra are both exact and
straightforward to obtain. While the software used in
the present work has not advanced to the level of that
used in previous applications nor does it take advan-
tage of the mass accuracy provided by the spectrometer,
the success resulting from its application promises that
further development may be very worthwhile.
Proteins used in this work were part of ongoing
studies of the biochemical mechanism of membrane
fusion being conducted in the Laboratory of Cellular
and Molecular Biophysics (LCMB), National Institute of
Child Health and Human Development (NICHD). For
reasons of accessible biochemistry, the model system
chosen for these studies are the secretory “cortical”
vesicles (CV) of sea urchin, S. purpuratus, eggs. Exten-
sive biochemical work [21–23] in LCMB over the last
several years has shown that the protein, or set of
proteins, responsible for the actual membrane fusion
process is not a member of any of the family of protein
complexes that have previously been hypothesized to
carry out the fusion role. This fact, coupled with no
better than a “sparse” representation of sea urchin
proteins in current data bases, suggests that the protein
of interest is likely to be unknown. It is probable that
this fusogenic protein, when found, will be homologous
to similar proteins in higher organisms, but those
proteins are also unknown or unidentified at present.
Thus, for the biochemical problem of interest, there is a
real need for the ability to determine a sufficient level of
sequence information to establish where further bio-
chemical and molecular biological work should be
focused. Our goal in this work was to take isolated
hydrophobic CV proteins and obtain as much sequence
information as possible from them, focusing on select-
ing previously undescribed proteins as candidates for
future work.
Methods
Sample Preparation
In-gel digestion of the SDS/PAGE separated proteins
was carried out using a procedure similar to that
published by the Association of Biomolecular Resource
Facilities (ABRF) [24]. The protein bands were excised,
washed, and in-gel digested using modified porcine
trypsin (Promega, Madison, WI). The resulting peptides
were extracted in two steps, partially dried, redissolved
in 0.1% TFA (Aldrich, Milwaukee, WI); salts were
removed using C18-ZipTip (Millipore, Bedford, MA)
solid phase extractions into 10 uL of 1:1 0.1% TFA:
acetonitrile.
Non-TOF-TOF Analyses
Protein digests were evaluated for suitability, in terms
of digestion effectiveness, for TOF-TOF investigation
using a MALDI-TOF instrument. A Voyager DE-STR
(Applied Biosystems, Framingham, MA) operated in
the reflector mode was used for these analyses. Samples
for both peptide mass fingerprinting and TOF-TOF
analysis were prepared using about 10% of the ex-
tracted digest, such that 1 uL of the extracted digest was
applied to a MALDI sample plate along with an equal
volume of matrix solution (saturated solution of a-
cyanocinnamic acid [Aldrich] in 1:1–0.1% TFA:acetoni-
trile).
In addition to the TOF-TOF analyses, an LC- MS/MS
analysis was performed on a portion of the extracted
peptides. The extracts were partially dried and resus-
pended in 9 uL of 0.1% TFA. An aliquot of this
resuspended sample, 2–5 uL, was injected onto a
packed capillary gradient MAGIC LC system (Michrom
Bioresources, Auburn, CA) operated at 400 nL/min
using a Michrom Magic constant pressure splitter.
Samples were separated using a 10 min linear gradient,
2–85% B (A, 5% acetonitrile in water with 0.5% acetic
acid, 0.005% TFA; B, 80% acetonitrile, 10% n-propanol,
10% water with 0.5% acetic acid, 0.005% TFA) with a
Vydac C18, 5 m particle, 300 Å pore packing material.
Columns, approximately 5 cm in length, were packed
by hand into a 75 m i.d. fused silica capillary PicoFrit
(New Objective, Woburn, MA). The LC effluent was
electrosprayed directly into the sampling orifice of an
LCQ DECA (Thermo Finnigan, San Jose, CA) using an
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adaptation of the microscale electrospray interface de-
veloped by T. D. Lee and co-workers [25]. The LCQ
DECA was operated in a mode that automatically
generated MS/MS spectra of the four most intense
peaks present in any single scan of the ion trap, pro-
vided these peaks exceeded a preset threshold. Peptide
partial internal sequence data produced by the LC-
MS/MS experiments were analyzed using MASCOT [5]
programs.
TOF-TOF Instrument
The latest configuration of the MALDI TOF-TOF is
shown in Figure 1. The concepts behind the design of
the instrument, as well as more detailed descriptions of
earlier versions of the instrument are found elsewhere
[26]. The apparatus is similar in geometry to a conven-
tional high quality reflectron MALDI TOF [27]. To
operate the instrument in both modes, however, there
are some key differences in the ion optics between the
TOF-TOF and the earlier MALDI TOF reflectron instru-
ment. In both MS and MS/MS mode, the TOF-TOF
operates at 200 Hz. In order to attain the higher repeti-
tion rate, the high voltage source 1 pulser circuit was
modified, and the conventional nitrogen laser was
replaced with a diode pumped Nd:YAG laser. A further
substantial difference between the conventional reflec-
tron TOF and the TOF-TOF is the use of a two stage
mirror that permits better focusing across the broad
energy range of fragments in MS/MS mode, without
sacrificing performance in MS mode.
The MS/MS capabilities of the instrument are facil-
itated through the addition of the optical elements
highlighted in the second source region of Figure 1—the
timed ion selectors, deceleration lens, collision cell, and
second source. When the instrument is operated in
MS/MS mode, the first source is operated as two stage,
delayed extraction, linear TOF MS, (typical acceleration
voltage, 8 kV) with an extraction delay time that pro-
duces optimal focusing for the chosen precursor in the
center of the timed ion selectors. The timed ion selectors
are operated as a double sided deflection gate, with the
first gate acting as the low mass gate and the second
gate as the high mass gate. When the laser fires, the low
mass gate is “on,” and the high mass gate is “off”—all
ions which enter the region of the timed ion selectors
are deflected from the optical axis of the instrument.
Using the precursor ion mass, the instrument geometry,
and the operating voltages, the arrival time of the
precursor ion to each of the gates is calculated. When
the precursor enters the plane of the low mass gate, the
voltage applied to the deflecting electrodes is rapidly
switched off, the precursor trajectory is unaffected.
After the precursor has passed through both electrodes,
the high mass gate is rapidly switched on, the remain-
ing ions are deflected from the axis of the spectrometer.
The width of the precursor mass window typically
functions to include the desired precursor mass and its
isotope cluster. While the paired timed ion selectors are
able to function with a resolution of 500 at m/z 1000,
losses in sensitivity occur under those circumstances.
Collision energy in the TOF-TOF is defined by the
potential difference between the source acceleration
voltage and the floating collision cell, typically set to 1
kV. The transmission of precursor ions into the collision
cell is optimized by the use of a decelerating lens. There
is a field free region at the potential of the collision cell,
which extends from the back of the decelerating lens to
the entrance of the second source. All fragments formed
from the ion of interest in this region, either through
unimolecular decomposition of “hot” ions (i.e., gas off
spectra) or through collision induced dissociation (i.e.,
gas on spectra), travel with essentially the same velocity
as the precursor, and thus enter the second source at the
same time as the precursor ion. When the collection of
precursor and fragment ions have entered the second
source, a high voltage pulse is applied to the source and
the ions are accelerated towards the detector. The firing
of the source serves as the starting point, i.e., t  0, for
the recording the fragment mass spectrum.
Data Analysis
Fragment ion spectra are smoothed and corrected to
zero baseline using routines embedded in Data Ex-
plorer (Applied Biosystems, Framingham, MA). A list
of intensity versus m/z for that portion of the spectrum
from 50 Da to the m/z of the precursor ion is sent to an
external file as ASCII data using another embedded
routine. This text file is manipulated further using a
series of programs written in PERL for the purposes of
this work.
At this stage of development these programs are
essentially computational aids to the step-wise deduc-
tion of peptide sequences. As shown below, the frag-
mentation spectra are quite clean and exhibit a high
signal-to-noise ratio, both of which make this rather
straightforward approach to sequence determination
effective. The second component of our present ap-
proach employs the relationship between the principal
C-terminal, y series, and N-terminal, b series, ions along
with the mass of the precursor ion:
Figure 1. Schematic of MALDI TOF-TOF instrument.
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bm MH  1  yn (1)
Presently, the programming does not incorporate con-
siderations of ammonia and water losses, the “a” series
ions nor any of the ion series typically associated with
high energy fragmentations, x-, w- c-, or d-. The pro-
gram uses nominal masses.
In the first step of the analysis, the text file generated
in Data Explorer is read by a PERL routine and the mass
of the precursor ion is inserted at the top of the list. This
modified list is used in further work. A starting point
for sequencing is selected, though likely candidates for
a b1 or a y1 ion are normally selected. If the peptides
originate from a trypsin digestion, the prominent m/z
175 ion, corresponding to a C-terminal arginine, is used
although complete sequences have be obtained from
Aspn digestions. After reading the PERL modified mass
list, another program then generates a list of candidate
peaks in the spectrum corresponding to the extension of
the starting mass by one residue. Candidates are re-
ported on the basis of their observed intensities. In
addition the report lists the masses and intensities of the
ions that are complementary to each possible extension,
see Eq 1. In this fashion, one proceeds along the
sequence step-wise, often from both ends of the peptide
sequence. Of course, one could choose to begin at the
precursor ion and extend to shorter peptides, with the
complimentary ions now becoming progressively
larger. Either process is continued until the peptide
terminal opposite the chosen start is reached, a possibly
correct sequence attained, or a point is reached beyond
which it is impossible to extend the chain, i.e., a failed
attempt.
The group of potential sequences are evaluated us-
ing an existing routine in the Data Explorer package. In
this routine, the Ion Fragmentation Calculator, a se-
quence is entered and ions of the original spectrum are
labeled, including sequence ions, internal fragments
and losses of water and ammonia. At this time there is
no scoring of the several candidate sequences, but
simply a user evaluation of the “best fit”. This “best fit”
is based on a visual evaluation of the data—including
the portion of the peaks that are labeled, i.e., can all of
the peaks be explained when all possible peptide frag-
ments are considered and stringent mass accuracy
criteria are used, and whether or not the observed
immonium and internal fragment ions are consistent
with the proposed sequence.
An additional confirmation, in cases where peptides
studied arise from proteins described in data bases, can
be obtained using a widely available search algorithm,
MASCOT [28]. For such confirmations, the modified
text files generated with the PERL routine described
above can be used to provide a file formatted appropri-
ately for MASCOT processing. A schematic of this
entire process is shown in Figure 2.
Results and Discussion
The first attempts at de novo sequencing of a peptide
were made using the standard material angiotensin I.
Fragmentation spectra were obtained from approxi-
mately 1000 laser shots of 100 fmole of this peptide in
both the simple metastable decomposition mode, “gas
off”, and the collision induced dissociation mode, “gas
on”. In the latter mode, collision cell gas pressures were
set at about 1  106 torr and collision energies at about
1 keV, nominal single collision conditions. A combina-
tion of gas on and gas off spectra showed, in addition to
what appeared to be a complete set of sequence ions, an
almost complete set of dipeptide internal fragment ions
and a number of tripeptide internal fragment ions. We
realized that the combination of di- and tripeptide ions
could be used by themselves, absent of virtually any
other information, to develop a sequence of the precur-
sor peptide. This fact is a consequence of a few simple
combinatorial rules that can be applied to such a set of
ions. We were able to show that the sequence of
angiotensin I could be correctly deduced from the
observed set of ions. Unfortunately, this simple and
attractive approach could not be generally applied and
was abandoned in future work. Subsequent efforts were
directed solely to sequencing of peptides derived from
sea urchin proteins.
The high signal to noise and overall appearance of a
typical TOF-TOF peptide fragmentation spectrum in
the gas off mode is shown in Figure 3. This spectrum
was obtained from 10% of the peptide mixture extracted
from an in-gel digest of a sea urchin protein, designated
Figure 2. Schematic of de novo sequencing process. Programs
were written in PERL for the processes shown in the rectangular
shapes.
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M7. Based on the intensity of the Coomassie Brilliant
Blue band that was digested, we estimate a few pmole
in the band, and thus a maximum of a few hundred
fmole in the sample spotted for TOF-TOF analysis.
Figure 3a shows the full mass range spectrum of a
peptide of MH  1049.43 in gas off mode, i.e., the
metastable fragmentation spectrum. Note that the base
peak intensity, m/z 899.33, is about 104. Figure 3b is an
expansion of the low mass region of the spectrum and
is normalized to m/z 534.31, a low intensity ion seen in
Figure 3a. The normalized intensity of Figure 3b is
about 700, or approximately 7% of the base peak
intensity. Inspection of 3b shows a S/N of greater than
50:1, and thus a S/N for the overall spectrum approach-
ing 104. The gas on fragment ion spectrum for this
precursor ion is shown in Figure 3c. In this case the
fragmentation spectrum is clearly richer than in the gas
off case, but this is a consequence of individual peptide
chemistry, as seen below. The spectra shown in Figure
3a and 3c are both the result of averaging 10,000 laser
shots. While the S/N of Figure 3c is lower than that of
Figure 3a, the gas on spectrum was acquired following
the acquisition of nine additional 10,000 shot spectra.
That is, Figure 3c is a 10,000 shot spectrum obtained
after 100,000 prior shots from the same sample. Figure
3d shows the fragmentation spectrum from the compa-
rable doubly charged ion, m/z 525, obtained from the
LC-MS/MS study done in parallel with the TOF-TOF
analysis. In this method, 25% of the peptide extract was
applied to the LC column.
MALDI TOF peptide mapping of the M7 digest
yielded no clear identification of the protein. Results
from parallel TOF-TOF and LC-MS/MS characteriza-
tion of the peptides of the M7 band, analyses run in
parallel, showed it to be a sea urchin protein known as
Cortical Vesicle P18, (CV-P18). These results, summa-
Figure 3. Comparison of TOF-TOF and LCQ DECA spectra for a precursor ion m/z 1049 (m/z 550
doubly charged). (a) Full TOF-TOF gas off spectrum. (b) Low mass region of (a). (c) Full TOF-TOF gas
on spectrum. (d) Ion trap MS/MS spectrum.
Table 1. Peptides sequenced from CV-P18 protein
Sequence m/z T/La
RDDEVFLRL 893.4 T
RTIAFTVERT 936.5 T/L
KRDDEVFLRL 1049.5 T
RVE LFKEAGKD LKS 1489.9 L
RLAP GLLDADADRPLFT GY LV YRE 2549.4 L
DFZYERb 857.4 T
aT  TOF-TOF, L  LCQ Ion Trap.
bPublished at N-terminal is . .VGDFZYER. See text.
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rized in Table 1, serve to illustrate several significant
aspects of the ability to obtain clean fragment spectra
with high signal to noise levels. This band was the first
set of peptides to which our de novo approach was
applied, and at the time they were undertaken, the
identity of the protein was uncertain.
Partial or complete sequences were obtained for six
peptides from this digest mixture, four using our de
novo routine and three using either or both of the
automated routines commonly applied to LC-MS/MS
data, SEQUEST and MASCOT. Both approaches iden-
tified the CV-P18 very reliably, but there are differences
between these two approaches that would be significant
if the protein involved were truly unknown.
The four sequences deduced from the TOF-TOF data,
designated in Table 1 with a “T” in the last column,
were complete. Significantly, the peptide at MH 857.4
yielded a sequence, DFZYER, where “Z” is taken to be
either lysine of glutamine. This sequence is part of the
overall CV-P18 protein, but could not be found in a list
of peptides produced by an in silico tryptic digestion of
the published sequence. The reason for this peptide
being absent from the list is that rather than a K or R
residue at the N-terminal of the peptide, the published
sequence reports a G, thus eliminating the possibility of
a peptide at the mass observed. The LC-MS/MS data
set found a peptide at m/z 857.4, but the automated data
interpretation routines using trypsin as an enzyme
could not associate this peptide with CV-P18 because of
the data base error. However, a search of the database
with no enzyme specificity should have identified this
peptide.
Of the three peptides found by the automated
searches of the LC-MS/MS data set, designated by an
“L” in Table 1, only one was complete, the peptide at
m/z 936.5. The spectrum for the ion at m/z 1049.5, shown
in Figure 3d, was uninterpretable by either SEQUEST or
MASCOT. Furthermore, the interpretation of the ions of
MH  1489.9 and 2549.4 yielded only partial se-
quences which did not identify dipeptides at both ends
of the m/z 1489.9 peptide and a tripeptide at the
N-terminal as well as two other dipeptides of the m/z
2549.4 peptide. The uncharacterized regions are shown
in bold italics in Table 2.
An additional aspect of the utility of TOF-TOF spec-
tra in de novo sequencing is discussed in conjunction
with Figure 4. Figure 4a is a full gas off mass spectrum
of a peptide resulting from trypsin digestion of a 105 kD
protein, designated BM3-5, isolated from a different sea
urchin CV preparation than that used to produce CV-
P18. The protonated precursor used in this example had
a nominal m/z of 1311. The spectrum feature near m/z
1104 is not associated with the peptide under study, a
fact shown by the negative mass defect associated with
the ion at m/z 1104.08 and with other ions nearby. This
ion can be assigned to a fragment of matrix impurity.
This gas off spectrum was used to generate a peptide
sequence: TDDDWEXVYR, where the one letter amino
acid code “X” is taken to be either leucine or isoleucine.
Several other candidate sequences were also generated
including: TETDWEXVYR, TDDVAMEXVYR, and TD-
DDWEDPYR. None of these four candidate sequences
included the abundant ion at m/z 510.23 as a sequence
ion. Applying the spectrum matching routine found in
Data Explorer to each of these potential sequences in
turn, we concluded that the decapeptide TDDDWEX-
VYR was the correct sequence. The ion at m/z 510.23 is
assigned as a water loss from the internal fragment for
WELV. A search of the NCBI nonredundant data base
using BLAST showed this peptide to be associated with
a known sea urchin GTP binding protein.
We hoped to confirm the sequence of the GTP
binding protein with the use of the more extensive
fragmentation, including the production of immonium
ions, that is characteristic of high energy CID and thus
observed in a gas on spectrum. The full mass range gas
on spectrum is shown in Figure 4b, again at a reduced
S/N compared to Figure 4a because of sample deple-
tion. Note that for this sample, the gas off fragmentation
spectrum is richer in the high mass region than is the
gas on spectrum, in contrast to the case shown in Figure
3. The low mass region of the gas on spectrum of the
nominal m/z 1311 precursor ion is shown in Figure 4c.
In addition to the strong immonium ions for the se-
quence proposed at m/z 86 (X), 136 (T), and 159 (W),
there are immonium ion peaks at m/z 70 (P), 87 (N), and
120 (F). It should be noted that m/z 70 and 87 can also be
ascribed to arginine, but at lower intensities than
Table 2. Summary peptide sequences from BM3- sea urchin proteins
Band m/z Sequence Protein Methoda
BM3-5 1311.58 TDDDWELVYR S. purpuratus GTP binding protein Tb
1448.54 RTPNDWELVYR S. purpuratus GTP binding protein M (15)
1575.67 FIPPDFADGIQSIR S. purpuratus GTP binding protein M (66)
BM3-7 852.38 STPYNDR (Xenopus Mps1) Tb
855 SVFSYPR (Drosophila T-related protein) Tb
BM3-10 1565.23 HSVDFVPEAGSQHR S. purpuratus CV31-53 protein M (67)
1636.34 SALTLTFSTDPVVRc S. purpuratus CV31-53 protein M (31)
1713.23 SFESPTVNXGDEFDR S. purpuratus CV31-53 protein T
2147.44 ALTLSSVPDLTFSTDPVVER S. purpuratus CV31-53 protein M (15)
aT  de novo by sequence extension, M()  MASCOT (Ion Score) where score 	40  identity.
b not identified by MASCOT.
c partial fragmentation, see text.
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present in this spectrum. None of the latter three
residues are in the proposed sequence, and only the
proline is present in the three alternates that were
subsequently rejected. This apparent anomaly was re-
solved by close inspection of the parent ion cluster of
the precursor ion, shown in Figure 4d. It is apparent
from this isotope cluster that what was taken as a single
precursor is in fact two, one at m/z 1311.59, sequenced
from the gas off spectrum, and a second peptide with a
precursor at m/z 1310.70. There was sufficient informa-
tion between the two spectra to obtain a sequence of
this second peptide as well. We determined its sequence
and, when searched against the NCBI nonredundant
data base using BLAST, was shown to have extensive
homology with a peptide from C. botolinum neuro-
toxin. This finding may be of some interest biochemi-
cally and is being investigated further.
A total of two additional bands from the preparation
of sea urchin CV were investigated using MALDI
TOF-TOF. The results of both our de novo sequencing
and the MASCOT searches of the fragmentation spectra
are summarized in Table 2. De novo sequencing iden-
tified an urchin GTP binding protein and suggested the
possibility of a heretofore undescribed urchin protein in
the 105 kDa band (BM3-5). The MASCOT search of the
data from this digest confirmed the presence of the GTP
binding protein in matching sequences of two other
peptides, one with a high enough score to confidently
identify the protein on its own accord. Interestingly,
MASCOT was unable to match the spectrum from the
nominal 1311 precursor with the GTP binding protein,
most likely because of the complexity of having a
mixture present. The LC-MS/MS study of this same
digest found three additional peptides associated with
the urchin GTP binding protein.
De novo sequencing of the weakly stained 62 kD
band (BM3-7) gave results from two peptides as shown
in Table 2, neither of which showed any homology with
known sea urchin proteins using BLAST. Neither the
MASCOT search of the TOF-TOF spectra nor the results
from the LC-MS/MS study of the digest from this band
yielded indication of the presence of known sea urchin
proteins. This band is clearly a candidate for future
study.
The fifteen residue peptide SFESPTVNXGDEFDR,
matching a sequence from a sea urchin protein known
as CV31-53, was found by de novo sequencing of the
peptide ion at m/z 1713.23. This peptide was also found
in the MASCOT search as were three other peptides
from the same protein and a trypsin autolysis fragment.
The two low scoring peptides found in the MASCOT
search, m/z 1636.34 and 2147.44 were matched using
spectra that were completely useless for our de novo
approach because of an almost complete lack of peptide
fragment ions. While these sparse spectra did not give
high scores in MASCOT, the interpretations made were
internally consistent.
Conclusion
We have shown that spectra resulting from TOF-TOF
fragmentations, both gas off and gas on, are responsive
to a straightforward approach to de novo sequencing.
When applied to spectra of peptides that quite possibly
originate from unknown proteins, our methods yield
results that are useful in interpreting the origins of the
bands and guiding future research directions. We have
found that using existing automated search routines
using the TOF-TOF spectra can be used as an initial
screening technique for selecting peptide spectra for
Figure 4. TOF-TOF spectrum of precursor m/z 1311. (a) Gas off spectrum. (b) Gas on spectrum. (c)
Low mass region of (b). (d) Gas off precursor parent iosotope cluster.
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further detailed study. These notable exceptions to the
utility of the more conventional methods show both the
power of the present approach and the need for using
de novo methods more frequently than may be other-
wise appreciated. The rather elementary programs de-
veloped for this work have proven to be effective for
interpreting the fragmentation spectra simply because
the spectra are generally very clean and distinct. Obvi-
ous future development will focus on incorporating the
concepts of the ion family or sequence spectrum [16–
20], as well as some scoring of the several candidate
sequences.
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